Transplant experts and leaders will collaborate with national colleagues to increase the number of transplants performed in the U.S. and raise awareness during local Donate Life event
NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its cutting-edge JuxtaFlow® Renal Assist Device (RAD). This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study, coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting. It marks a significant leap forward in safeguarding kidney function for patients undergoing cardiac surgeries, addressing a key challenge in cardiothoracic surgery and critical care.
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
Faculty, scientists, and urologists from UCLA Health Urology will present research data on the latest discoveries and innovations in urology at the 2024 American Urological Association’s (AUA) Annual Meeting in San Antonio, Texas, May 3-6.
APOL1 Kidney Disease (APOL1 KD) is a genetic condition that affects people who carry a high-risk APOL1 gene variant. Most people with those variants are of African ancestry.
Therapeutic tool used for children with kidney issues stemming from sepsis
Treatment for lung condition could help patients with sickle cell disease control complications from hypertension and kidney damage
New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time.
UC Davis Medical Center has become the first hospital in Western U.S. to perform a successful transcatheter tricuspid valve repair procedure with a groundbreaking catheter.
Hackensack University Medical Center's Kidney Transplant Program is among the fastest-growing and largest in the nation.
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood.
Combining a low dose of blood pressure medication with a higher intake of dietary-resistant starch might help stave off diabetic kidney disease, according to results from a new animal study. Researchers will present their work this week at the American Physiology Summit.
Nature Reviews Nephrology published a landmark international consensus statement titled "Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus." Authored by a coalition of leading experts, stakeholders, and nephrology societies, the publication highlights critical policy, advocacy, and implementation needs to alleviate the growing burden of kidney disease worldwide.
In recognition of Donate Life Month, Loyola University Medical Center will host its 32nd annual candle lighting ceremony in honor of organ and tissue donors, their families and countless health care team members.
A new study published April 4 in Cancer Cell was led by Yale Cancer Center researchers, who collaborated with investigators nationally to differentiate the molecular subgroups of RCC tumors to better understand how their makeup might affect treatment responses.
• Sedentary time decreased, stepping time increased, and number of steps per day increased among patients with chronic kidney disease assigned to the ‘Sit Less, Interact, Move More’ intervention. • These effects were not sustained after 20 weeks, however.
St. Jude Children’s Research Hospital scientists studying bilateral Wilms tumor found that chemotherapy resistance correlates with tumors favorable to surgery, reducing the need for additional therapy.
B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according to a new study led by Gil Yosipovitch, M.D., director of the Miami Itch Center, and Santosh Mishra, Ph.D., a neuroscientist and associate professor at the North Carolina State College of Veterinary Medicine.
For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.
Delivering on its commitment to increase Americans’ access to kidney transplant by improving the transparency and efficiency of our nation’s transplant network, Congress this week approved a much-needed $23 million federal funding increase in fiscal year (FY) 2024 for the Health Resources and Services Administration (HRSA), the agency responsible for overseeing the Organ Procurement and Transplantation Network (OPTN).
As Rutgers' biomedical education, research and clinical care arm enters its second decade, new strategies are delivering healthier futures for New Jersey and beyond
The American Society of Nephrology (ASN) and Home Dialysis University (HDU) launched a collaboration in 2023 to improve nephrology trainees’ knowledge, proficiency, and exposure to home dialysis therapies.
The April issue of the Journal of the American College of Surgeons (JACS) features new research on topics ranging from colorectal cancer and social vulnerability to operating room supply costs, the rise in school shootings since 1970, and the impact of permitless open carry laws on suicide rates, among others.
Supplementing expecting mothers with acetyl-CoA, a sugar-derived molecule, may ensure proper development of nephrons in developing fetuses, lowering their risk of high blood pressure and chronic kidney disease later in life.
A collaborative study between a bariatric and transplant surgery team has introduced new hope for patients suffering from end-stage renal disease (ESRD) who are also struggling with obesity. The study authors explored the outcomes of metabolic and bariatric surgery in ESRD patients and whether the surgery can improve their eligibility for kidney transplants. The findings are published in the Journal of the American College of Surgeons (JACS).
Are you one of the 530 million people who have diabetes? If so, it is also likely you have kidney disease. It's one of the most pressing global health challenges and scientists are scrambling to find new treatments and diagnostic markers for diabetic kidney disease. University of South Australia Research Fellow Dr Jantina Manning explains an exciting new discovery in her lab that could provide hope for millions of people living with diabetes and associated kidney disease. Thursday 14 March is World Diabetes Day.
It has been well established that people who live in rural areas in the U.S. are more likely to have diabetes and experience barriers to managing their condition compared to those who live in the suburbs and cities.
The American Society of Nephrology (ASN) commends congressional leaders on the House Ways and Means committee for advancing the Kidney PATIENT Act, bipartisan legislation to maintain patient access to oral-only medications by retaining coverage through Medicare Part D. More than 500,000 patients undergoing dialysis require numerous medications to manage their health, and, for many patients this includes certain oral-only medications, such as phosphate binders. These vital oral-only medications are best dispensed by pharmacies, who have dedicated infrastructure suited to promoting at-home medication adherence and are more accessible to patients.
Loyola Medicine Nephrologist Sylvester Barnes is available to discuss a new study which showed Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for February 2024.
People who are overall healthy and living with well-controlled Type 2 diabetes can donate a kidney, thanks to a change in national policy.
At a hearing today focused on supporting patients with rare diseases, the House Energy and Commerce Health Subcommittee will consider Honor Our Living Donors Act (H.R. 6020), legislation to improve support for living organ donors.
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preserving the transplanted organs.
Human pluripotent stem cell (hPSC)-derived kidney organoids share similarities with the fetal kidney. However, the current hPSC-derived kidney organoids have some limitations, including the inability to perform nephrogenesis and lack of a c
Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure. Their findings, detailed in a paper published in the peer-reviewed journal Science, could lead to the development of noninvasive tests to detect kidney scarring and, eventually, new therapies to reverse the condition.
Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health. When UT Southwestern Medical Center researchers removed receptors for this hormone from mouse kidneys, the animals developed symptoms akin to chronic kidney disease (CKD).
Atrium Health's Division of Abdominal Transplant, Carolinas Medical Center (DAT Atrium), LifeShare Carolinas, one of nation's leading Organ Procurement Organizations, and BMI OrganBank, a developer of organ perfusion systems based in Winston-Salem, North Carolina, announced today that their organizations have partnered to develop and launch the nation's first Organ Banking technology, which will greatly expand the possibilities for organ preservation and reconditioning.
The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.
Dr. Yamamoto et al. found the several uremic toxins as one of causes of itching in hemodialysis patients.
Two hard-to-match transplant patients 250 miles apart are starting 2024 on a new path to healthy lives.
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
People who experience heat stress during exercise may need more recovery time to let their muscles heal, according to a new mouse study published ahead of print in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in Cardiovascular Diabetology.
For 21 years, nurses have consistently been the most trusted profession, according to the yearly Gallup poll. (The new poll will be issued by the end of January). Dr Rushton, who specializes in burnout, will speak on trust, moral injury, and how nurses cope in this day and age.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
